Relievant Medsystems Secures $36 Million for INTRACEPT

Relievant Medsystems secured US $36MM in equity financing. Proceeds will support clinical studies, portfolio expansion and commercialization of the INTRACEPT® Intraosseous Nerve Ablation System.

Histogenics Closes $30.0 Million Private Placement

Histogenics closed its previously-announced US $30.0MM private placement. Funds will support development of NeoCart® novel cartilage repair therapy, including completion of the ongoing Phase III clinical trial.

Spineart Secures Investment

Spineart secured a 30MM (~US $33MM) investment. Proceeds will support sales, geographical expansion in markets such as the U.S. and Europe and product development.

Histogenics Announces $30.0MM Private Placement

Histogenics seeks to raise ~US $30.0MM in a private placement. Net proceeds will support development of NeoCart® cartilage repair therapy, including completion of an ongoing Phase III clinical trial.

Lattice Biologics Raises $0.75MM in Private Placement

Lattice Biologics closed a private placement for gross proceeds of up to US $0.75MM to fund M&A and the acquisition of donors to support production of an amniotic fluid product for regenerative use. The novel regenerative therapeutic will target osteoarthritis, spine, sports-medicine, foot/ankle and other indications. 

Rotation Medical Completes $12MM Series B Financing

Rotation Medical completed a US $12MM Series B extension financing. Proceeds will support U.S. commercialization of its rotator cuff repair system, comprising a proprietary bioinductive implant and disposable instruments.